Vitamin D and autism, what’s new?

Reviews in Endocrine and Metabolic Disorders

Volumn 18, Issue 2, 2017, Pages 183-193

  Cannell, John Jacob ^a  

^a Vitamin D Council   (United States)

Author keywords

25(OH)D; ASD; Autism; CARS; Prevention of autism; Treatment of autism; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; NEUROSTEROID; VITAMIN D;

AUTISM; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILDHOOD; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; DRUG OVERDOSE; DRUG SAFETY; EPIDEMIOLOGICAL DATA; HEREDITY; HUMAN; INFANCY; LOW DRUG DOSE; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMISSION; PREGNANCY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX DIFFERENCE; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ADULT; BLOOD; CHILD; COMPLICATION; DIETARY SUPPLEMENT; FEMALE; INFANT; NEWBORN; PHYSIOLOGY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRESCHOOL CHILD; PSYCHOLOGY;

ADULT; AUTISTIC DISORDER; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85013127855     PISSN: 13899155     EISSN: 15732606     Source Type: Journal    
DOI: 10.1007/s11154-017-9409-0     Document Type: Review

References (103)

1. Larocque R. Deaths at an early age in the city of Quebec, 17th-19th centuries. Can Bull Med Hist. 1999;16:341–61.
2. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062–72.
3. Thacher TD, Fischer PR, Tebben PJ, Singh RJ, Cha SS, Maxson JA, Yawn BP. Increasing incidence of nutritional rickets: a population-based study in Olmsted County. Minnesota Mayo Clin Proc. 2013;88(2):176–83.
4. Bhat S, Acharya UR, Adeli H, Bairy GM, Adeli A. Autism: cause factors, early diagnosis and therapies. Rev Neurosci. 2014;25(6):841–50. doi:10.1515/revneuro-2014-0056. Review
5. Cannell JJ. Autism and vitamin D. Med Hypotheses. 2008;70(4):750–9.
6. Cannell JJ. Autism, will vitamin D treat core symptoms? Med Hypotheses. 2013;81(2):195–8.
7. Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91(1):8–15.
8. Waldman M, Nicholson S, Adilov N. Does television cause autism? National Bureau of Economic Research Working Group. 12632. 2006. http://www.nber.org/papers/w12632. Accessed 1/19/2017.
9. Grant WB, Cannell JJ. Autism prevalence in the United States with respect to solar UV-B doses: an ecological study. Dermatoendocrinol. 2013;5(1):159–64.
10. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco bay area. Environ Health Perspect. 2006;114(9):1438–44.
11. Wai KM, Yu PK, Lam KS. Reduction of solar UV radiation due to urban high-rise buildings--a coupled Modelling study. PLoS One. 2015;10(8):e0135562.
12. Vieira SE. The health burden of pollution: the impact of prenatal exposure to air pollutants. Int J Chron Obstruct Pulmon Dis. 2015;10:1111–21.
13. Agarwal KS, Mughal MZ, Upadhyay P, Berry JL, Mawer EB, Puliyel JM. The impact of atmospheric pollution on vitamin D status of infants and toddlers in Delhi. India Arch Dis Child. 2002;87:111–3.
14. Kelishadi R, Moeini R, Poursafa P, Farajian S, Yousefy H, Okhovat-Souraki AA. Independent association between air pollutants and vitamin D deficiency in young children in Isfahan. Iran Paediatr Int Child Health. 2014;34(1):50–5.
15. Baïz N, Dargent-Molina P, Wark JD, Souberbielle JC, Slama R, Annesi-Maesano I. EDEN mother-child cohort study group. Gestational exposure to urban air pollution related to a decrease in cord blood vitamin d levels. J Clin Endocrinol Metab. 2012;97(11):4087–95.
16. https://www.vitamindcouncil.org/wp-content/uploads/2012/03/Sunlight-for-Babies.pdf. Accessed 1–21-2017.
17. Gies P, Makin J, Dobbinson S, Javorniczky J, Henderson S, Guilfoyle R, Lock J. Shade provision for toddlers at swimming pools in Melbourne. Photochem Photobiol. 2013;89(4):968–73.
18. Walker RB, Conn JA, Davies MJ, et al. Mothers’ views on feeding infants around the time of weaning. Public Health Nutr. 2006;9(6):707–13.
19. Szachta P, Skonieczna-Żydecka K, Adler G, Karakua-Juchnowicz H, Madlani H, Ignyś I. Immune related factors in pathogenesis of autism spectrum disorders. Eur Rev Med Pharmacol Sci. 2016;20(14):3060–72.
20. Liu L, Zhang D, Rodzinka-Pasko JK, Li YM. Environmental risk factors for autism spectrum disorders. Nervenarzt. 2016. Review.
21. Risch N, Hoffmann TJ, Anderson M, Croen LA, Grether JK, Windham GC. Familial recurrence of autism spectrum disorder: evaluating genetic and environmental contributions. Am J Psychiatry. 2014;171(11):1206-13. doi:10.1176/appi.ajp.2014.13101359.
22. Zhang C, Qiu C, Hu FB, David RM, van Dam RM, Bralley A, Williams MA. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One. 2008;3(11):e3753.
23. Nahum Sacks K, Friger M, Shoham-Vardi I, Abokaf H, Spiegel E, Sergienko R, Landau D, Sheiner E. Prenatal exposure to gestational diabetes mellitus as an independent risk factor for long-term neuropsychiatric morbidity of the offspring. Am J Obstet Gynecol. 2016;215(3):380.e1–7.
24. Curran EA, O'Neill SM, Cryan JF, Kenny LC, Dinan TG, Khashan AS, Kearney PM. Research review: birth by caesarean section and development of autism spectrum disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J Child Psychol Psychiatry. 2015;56(5):500–8.
25. Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab. 2009;94(3):940–5.
26. Frye RE, Rossignol DA. Identification and treatment of pathophysiological comorbidities of autism Spectrum disorder to achieve optimal outcomes. Clin Med Insights Pediatr. 2016;10:43–56.
27. Holló A, Clemens Z, Lakatos P. Epilepsy and vitamin D. Int J Neurosci. 2014;124(6):387–93.
28. Abbasnezhad A, Amani R, Hajiani E, Alavinejad P, Cheraghian B, Ghadiri A. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol Motil. 2016;28(10):1533–44.
29. Garabe’dian M, Jacqz E, Guillozo H, et al. Elevated plasma 1,25-dihydroxyvitamin D concentrations in infants with hypercalcemia and an elfin facies. N Engl J Med 1985;312(15):948–952.
30. Knudtzon J, Aksnes L, Akslen LA, Aarskog D. Elevated 1,25- dihydroxyvitamin D and normocalcaemia in presumed familial Williams syndrome. Clin Genet. 1987;32(6):369–74.
31. Ng R, Järvinen A, Bellugi U. Toward a deeper characterization of the social phenotype of Williams syndrome: the association between personality and social drive. Res Dev Disabil. 2014;35(8):1838–49.
32. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353–73.
33. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357(3):266–281. Review.
34. Fishman MP, Lombardo SJ, Kharrazi FD. Vitamin D deficiency among professional basketball players. Orthop J Sports Med. 2016;4(7):2325967116655742.
35. Mazahery H, Camargo Jr CA, Conlon C, Beck KL, Kruger MC, von Hurst PR. Vitamin D and autism Spectrum disorder: a literature review. Nutrients. 2016;8(4):236.
36. Hallerhan MM. The effect of rickets on the mental development of young children. Arch Psychol. 1938;229:1–67.
37. Gilmour A. The mental condition in rickets. School Hygiene. 1912;9:6–16.
38. Cannell JJ. On the aetiology of autism. Acta Paediatr. 2010;99(8):1128–30.
39. Zaky EA, et al. Prevalence of Autism Spectrum Disorders in Vitamin D Deficient or Insufficient Rickets IJSR. 2015;4:6.
40. Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012;14(3):281–92. Review
41. Koch CA, Diamanti-Kandarakis E. Introduction to endocrine disrupting chemicals--is it time to act? Rev Endocr Metab Disord. 2015;16(4):269–70.
42. Fujiwara T, Morisaki N, Honda Y, Sampei M, Tani Y. Chemicals, nutrition, and autism Spectrum disorder: a mini-review. Front Neurosci. 2016;10:174.
43. Surén P, Gunnes N, Roth C, Bresnahan M, Hornig M, Hirtz D, Lie KK, Lipkin WI, Magnus P, Reichborn-Kjennerud T, Schjølberg S, Susser E, Oyen AS, Smith GD, Stoltenberg C. Parental obesity and risk of autism spectrum disorder. Pediatrics. 2014;133(5):e1128–38.
44. Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Pereira-Santos M, costa PR, Assis AM, Santos CA, Santos DB. Obes Rev. 2015;16(4):341–9.
45. Patrick L. Mercury toxicity and antioxidants: part 1: role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity. Altern Med Rev. 2002;7(6):456–71. Review
46. Dawodu A, Wagner CL. Prevention of vitamin D deficiency in mothers and infants worldwide - a paradigm shift. Paediatr Int Child Health. 2012;32(1):3–13.
47. Dawodu A, Zalla L, Woo JG, Herbers PM, Davidson BS, Heubi JE, Morrow AL. Heightened attention to supplementation is needed to improve the vitamin D status of breastfeeding mothers and infants when sunshine exposure is restricted. Matern Child Nutr. 2014;10(3):383–97.
48. Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol. 2006;92:26–32.
49. http://www.strategyr.com/MarketResearch/Sun_Care_Products_Market_Trends.asp. Accessed 1/23/2017
50. Council on Scientific Affairs. Harmful effects of ultraviolet radiation. JAMA. 1989;262:380–384.
51. Hall HI, Jorgensen CM, McDavid K, Kraft JM, Breslow R. Protection from sun exposure in US white children ages 6 months to 11 years. Public Health Rep. 2001;116(4):353–61.
52. Ali A, Cui X, Eyles D. Developmental vitamin D deficiency and autism: putative pathogenic mechanisms. J Steroid Biochem Mol Biol. 2016. doi:10.1016/j.jsbmb.2016.12.018.
53. DeLuca GC, Kimball SM, Kolasinski J, et al. Review: the role of vitamin D in nervous system health and disease. Neuropathol Appl Neurobiol. 2013;39(5):458–84.
54. Cannell JJ, Grant WB. What is the role of vitamin D in autism? Dermatoendocrinol. 2013;5(1):199–204.
55. Huang YN, Ho YJ, Lai CC, Chiu CT, Wang JY. 1,25-dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. J Neuroinflammation. 2015;12:147.
56. Kočovská E, Fernell E, Billstedt E, et al. Vitamin D and autism: clinical review. Res Dev Disabil. 2012;33(5):1541–50.
57. Patrick RP, Ames BN. Vitamin D Hormone regulates serotonin synthesis. Part 1: relevance for autism. FASEB J 2014;28(6):2398–2413.
58. Smaga I, Niedzielska E, Gawlik M, Moniczewski A, Krzek J, Przegaliński E, Pera J, Filip M. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep. 2015;67(3):569–80.
59. Cortelazzo A, De Felice C, Guerranti R, Signorini C, Leoncini S, Zollo G, et al. Expression and oxidative modifications of plasma proteins in autism spectrum disorders: interplay between inflammatory response and lipid peroxidation. Proteomics Clin Appl. 2016;10(11):1103-1112. doi:10.1002/prca.201500076.
60. Gatti D, Idolazzi L, Fassio A. Vitamin D: not just bone, but also immunity. Minerva Med. 2016;107(6):452-460.
61. Bakdash G, van Capel TM, Mason LM, et al. Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells. Vaccine. 2014;32(47):6294–302.
62. Arnson Y, Itzhaky D, Mosseri M, Barak V, Tzur B, Agmon-Levin N, Amital H. Vitamin D inflammatory cytokines and coronary events: a comprehensive review. Clin Rev Allergy Immunol. 2013;45(2):236–47.
63. Krakowiak P, Goines PE, Tancredi DJ. Ashwood P. Hertz-Picciotto I, et al. Neonatal cytokine profiles associated with autism spectrum disorder. Biol Psychiatry: Hansen RL; 2015.
64. Wrzosek M, Łukaszkiewicz J, Wrzosek M, Jakubczyk A, Matsumoto H, Piątkiewicz P, Radziwoń-Zaleska M, Wojnar M, Nowicka G. Vitamin D and the central nervous system. Pharmacol Rep. 2013;65(2):271–8. Review
65. Zhang Q, Cheng Y, He M, Li T, Ma Z, Cheng H. Effect of various doses of vitamin D supplementation on pregnant women with gestational diabetes mellitus: a randomized controlled trial. Exp Ther Med. 2016;12(3):1889–95.
66. Srivastava DP. Two-step wiring plasticity--a mechanism for estrogen-induced rewiring of cortical circuits. J Steroid Biochem Mol Biol. 2012;131(1–2):17–23.
67. Höfer P, Lanzenberger R, Kasper S. Testosterone in the brain: neuroimaging findings and the potential role for neuropsychopharmacology. Eur Neuropsychopharmacol. 2013;23(2):79–88.
68. Payne JD, Nadel L. Sleep, dreams, and memory consolidation: the role of the stress hormone cortisol. Learn Mem. 2004;11(6):671–8. Review
69. Kesby JP, Eyles DW, Burne TH, McGrath JJ. The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol. 2011;347(1–2):121–7.
70. Shailesh H, Gupta I, Sif S, Ouhtit A. Towards understanding the genetics of Autism. Front Biosci (Elite Ed). 2016;8:412–26.
71. Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2016;25(4):341–50.
72. Coşkun S, Şimşek Ş, Camkurt MA, Çim A, Çelik SB. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder. Gene. 2016;588(2):109–14.
73. Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Sconberg JL, Schmidt LC, Volk HE, Tassone F. Selected vitamin D metabolic gene variants and risk for autism spectrum disorder in the CHARGE study. Early Hum Dev. 2015;91(8):483–9.
74. Nissen J, Rasmussen LB, Ravn-Haren G, Andersen EW, Hansen B, Andersen R, Mejborn H, Madsen KH, Vogel U. Common variants in CYP2R1 and GC genes predict vitamin D concentrations in healthy Danish children and adults. PLoS One. 2014;9(2):e89907.
75. Fernell E, Bejerot S, Westerlund J, Miniscalco C, Simila H, Eyles D, Gillberg C, Humble MB. Autism spectrum disorder and low vitamin D at birth: a sibling control study. Mol Autism. 2015;6:3.
76. Magnusson C, Lundberg M, Lee BK, Rai D, Karlsson H, Gardner R, Kosidou K, Arver S, Dalman C. Maternal vitamin D deficiency and the risk of autism spectrum disorders: population-based study. BJPsych Open. 2016;2(2):170–2.
77. Vinkhuyzen AA, Eyles DW, Burne TH, Blanken LM, Kruithof CJ, Verhulst F, et al. Gestational vitamin D deficiency and autism-related traits: the Generation R Study. Mol Psychiatry. 2016. doi:10.1038/mp.2016.213.
78. Chen J, Xin K, Wei J, Zhang K, Xiao H. Lower maternal serum 25(OH) D in first trimester associated with higher autism risk in Chinese offspring. J Psychosom Res. 2016;89:98–101.
79. Karohl C, Su S, Kumari M, Tangpricha V, Veledar E, Vaccarino V, Raggi P. Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr. 2010;92(6):1393–8.
80. Fan X, Warner M, Gustafsson JA. Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons. Proc Natl Acad Sci U S A. 2006;103:19338–43.
81. Baksi SN, Kenny AD. Estradiol-induced stimulation of 25-hydroxyvitamin D3-1-hydroxylase in vitamin D-deficient Japanese quail. Pharmacology. 1980;20(6):298–303.
82. Harmon QE, Umbach DM, Baird DD. Use of estrogen-containing contraception is associated with increased concentrations of 25-hydroxy vitamin D. J Clin Endocrinol Metab. 2016;101(9):3370–7.
83. Olmos-Ortiz A, García-Quiroz J, López-Marure R, González-Curiel I, Rivas-Santiago B, Olivares A, Avila E, Barrera D, Halhali A, Caldiño F, Larrea F, Díaz L. Evidence of sexual dimorphism in placental vitamin D metabolism: testosterone inhibits calcitriol-dependent cathelicidin expression. J Steroid Biochem Mol Biol. 2016;163:173–82.
84. Alfawaz HA, Bhat RS, Al-Ayadhi L, et al. Protective and restorative potency of vitamin D on persistent biochemical autistic features induced in propionic acid-intoxicated rat pups. BMC Complement Altern Med. 2014;14:416.
85. Jia F, Wang B, Shan L, Xu Z, Staal WG, Du L. core Symptoms of autism improved after vitamin D supplementation. Pediatrics 2015;135(1):e196–e198.
86. Saad K, Abdel-Rahman AA, Elserogy YM, et al. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr Neurosci. 2015;19(8):346-351.
87. Feng J, Shan L, Du L. et al. Clinical improvement following vitamin D3 supplementation in autism Spectrum disorder. Nutr Neurosci. 2016. doi:10.1080/1028415X.2015.1123847.
88. İbili Ucuz II İ, Dursun OB, Esin IS, et al. The relationship between vitamin D, autistic spectrum disorders, and cognitive development: do glial cell line-derived neurotrophic factor and nerve growth factor play a role in this relationship? Int J Dev Disab. 2015;61(4):222–30.
89. Saad K, Abdel-Rahman AA, Elserogy YM. Al-Atram AA. Othman HA, et al. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder. J Child Psychol Psychiatry: El-Houfey AA. 2016. doi:10.1111/jcpp.12652.
90. Stubbs G, Henley K, Green J. Autism: will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? Med Hypotheses. 2016;88:74–8.
91. Hollis BW, Wagner CL. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr. 2004;80(6 Suppl):1752S–8S.
92. Við Streym S, Højskov CS, Møller UK, Heickendorff L, Vestergaard P, Mosekilde L, Rejnmark L. Vitamin D content in human breast milk: a 9-mo follow-up study. Am J Clin Nutr 2016;103(1):107–114.
93. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88(6):1519–27.
94. Lebbé C, Robert C, Ricard S, Sassolas B, Grange F, Saiag P, Lhomel C, Mortier L. Evolution of sun-protection measures for children. J Eur Acad Dermatol Venereol. 2015;29(Suppl 2):20–2.
95. Holick MF. Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc. 1987;46:1876–82.
96. Ekwaru JP, Zwicker JD, Holick MF, Giovannucci E, Veugelers PJ. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One. 2014;9(11):e111265.
97. Wagner CL, McNeil RB, Johnson DD, Hulsey TC, Ebeling M, Robinson C, Hamilton SA, Hollis BW. Health characteristics and outcomes of two randomized vitamin D supplementation trials during pregnancy: a combined analysis. J Steroid Biochem Mol Biol. 2013;136:313–20.
98. Wagner CL, McNeil R, Hamilton SA, Winkler J, Rodriguez Cook C, Warner G, Bivens B, Davis DJ, Smith PG, Murphy M, Shary JR, Hollis BW. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol. 2013;208(2):137.e1–13.
99. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res. 2011;26(10):2341–57.
100. Luxwolda MF, Kuipers RS, Kema IP, Dijck-Brouwer DA, Muskiet FA. Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l. Br J Nutr. 2012;108(9):1557–61.
101. Hollis BW, Wagner CL, Howard CR, Ebeling M, Shary JR, Smith PG, Taylor SN, Morella K, Lawrence RA, Hulsey TC. Maternal versus infant vitamin D supplementation during lactation: a randomized controlled trial. Pediatrics. 2015;136(4):625–34.
102. Briefel R, Hanson C, Fox MK, et al. Feeding infants and toddlers study: do vitamin and mineral supplements contribute to nutrient adequacy or excess among US infants and toddlers? J Am Diet Assoc 2006;106(1 Suppl. 1):S52–65.
103. Perrine CG, Sharma AJ, Jefferds ME, et al. Adherence to vitamin D recommendations among US infants. Pediatrics. 2010;125(4):627–32.